|
|
||||||||
1 Institut de Cancérologie et d'Immunogénétique, 14, avenue Paul Vaillant Couturier, 94800 Villejuif, France
2 Institut de Recherches Scientifiques sur le Cancer, 7, rue Guy Mocquet, 94802 Villejuif Cedex, France
3 Institut Pasteur, Unité d'Oncologie Virale, 25, rue du Docteur-Roux, 75015 Paris, France
and4 Aichi Cancer Center Research Institute, Laboratory of Viral Oncology, Chikusa-ku, Nagoya 464, Japan
The polyoxotungstate HPA-23 was found to exert a differential effect on the induction of EpsteinBarr virus early antigen in Raji cells induced with 5-iodo-2'-deoxyuridine (IUdR). Thus, treatment of Raji cells concomitantly with IUdR and HPA-23 inhibited early antigen expression, and the extent of inhibition was proportional to the duration of treatment with HPA-23. In contrast, pretreatment of Raji cells with HPA-23 prior to induction with IUdR stimulated early antigen expression in exponentially multiplying but not in stationary-phase cells. HPA-23 alone had no effect one arly antigen expression in Raji cells. Activation of the latent EpsteinBarr virus genome by IUdR is dependent upon incorporation of the thymidine analogue into cellular DNA during the S-phase of the cell cycle. Synthesis of EpsteinBarr virus DNA also takes place during S-phase, suggesting a possible participation in this process of cellular DNA polymerase
which is thought to be responsible for cellular DNA replication and the activity of which increases several-fold during S-phase. Treatment of Raji cells with HPA-23 caused a marked decrease in DNA polymerase
activity, which could result in an inhibition of IUdR incorporation leading to the observed reduction of early antigen expression in cells treated concomitantly with IUdR and HPA-23.
Keywords: EBV, induction, polyoxotungstate
Received 12 August 1983;
accepted 13 January 1984.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |